JUDITH LYLE: Open Payments
NPI 1972365757 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$699 in 8 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $305 · 2025 $699
Food & beverage: $699
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $154 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Amgen Inc. | 1 | $123 |
| E.R. Squibb & Sons, L.L.C. | 1 | $114 |
| Alnylam Pharmaceuticals Inc. | 1 | $95 |
| Novartis Pharmaceuticals Corporation | 1 | $45 |
| CVRx, Inc. | 1 | $22 |
| Edwards Lifesciences Corporation | 1 | $21 |
Products named: SYNCHROMEDII, JARDIANCE, REPATHA, CAMZYOS, AMVUTTRA, LEQVIO, Barostim Neo System, PASCAL.
Industry payments across AZ — which companies pay providers there.
